Verapamil and angiotensin-converting enzyme inhibitors in patients with coronary artery disease and reduced left ventricular ejection fraction. (Q53986171)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Verapamil and angiotensin-converting enzyme inhibitors in patients with coronary artery disease and reduced left ventricular ejection fraction.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8677892

Verapamil and angiotensin-converting enzyme inhibitors in patients with coronary artery disease and reduced left ventricular ejection fraction. (English)

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8677892

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

ejection fraction

1 reference

based on heuristic

inferred from title

author name string

Hansen JF

1

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8677892

Tingsted L

2

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8677892

Rasmussen V

3

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8677892

Madsen JK

4

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8677892

Jespersen CM

5

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8677892

language of work or name

0 references

publication date

1 June 1996

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8677892

American Journal of Cardiology

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8677892

77

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8677892

16

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8677892

16D-21D

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8677892

Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Secondary prevention with verapamil after myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Effects of intravenous verapamil on left ventricular relaxation and filling in stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

The influence of verapamil and its isomers on vulnerability to ventricular fibrillation during acute myocardial ischemia and adrenergic stimulation in isolated rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Comparative study of the effect of slow channel inhibiting agents on ischemia-induced conduction delay as relevant to the genesis of ventricular fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Calcium antagonists and cardiac noradrenaline release in ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Platelet aggregability in vivo is attenuated by verapamil but not by metoprolol in patients with stable angina pectoris.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Reduction of ischemic events with angiotensin-converting enzyme inhibitors: lessons and controversy emerging from recent clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Chronic oral pretreatment with the angiotensin converting enzyme inhibitor, trandolapril decreases ventricular fibrillation in acute ischaemia and reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Effect of captopril, an angiotensin-converting enzyme inhibitor, in patients with angina pectoris and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Effects of captopril on ischemia and dysfunction of the left ventricle after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Ventricular arrhythmias in the acute and chronic phases after acute myocardial infarction. Effect of intervention with captopril

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Systemic and cardiac neuroendocrine activation and severity of myocardial ischemia in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Detection of myocardial ischaemia by transthoracic leads in ambulatory electrocardiographic monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Are right and left ventricular ejection fractions equal? Ejection fractions in normal subjects and in patients with first acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Cross-sectional echocardiography in acute myocardial infarction: detection and localization of regional left ventricular asynergy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Placebo controlled trial of felodipine in patients with mild to moderate heart failure. UK Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

The effect of verapamil on major events in patients with impaired cardiac function recovering from acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

ACE inhibitors after myocardial infarction: patient selection or treatment for all?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement Study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Prevalence of transient myocardial ischaemia during the first year after a myocardial infarction. Effect of treatment with verapamil. The Danish Study Group on Verapamil in Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900303-7

7 January 2021

Identifiers

10.1016/S0002-9149(96)00303-7

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8677892

1 reference

Europe PubMed Central

23 May 2018

http://europepmc.org/abstract/MED/8677892

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53986171&oldid=1866544790"